Cardiovascular manifestations of neurologic disease

Handbook of Clinical Neurology

Volumn 119, Issue , 2014, Pages 3-17

  Dombrowski, Keith ^a   Laskowitz, Daniel ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autonomic neuropathy; Head injury; Muscular dystrophy; Neurogenic stunned myocardium; Stroke; Subarachnoid hemorrhage; Takotsubo

Indexed keywords

ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; HEAD INJURY; HEART; HUMAN; MUSCULAR DYSTROPHY; NERVE TRACT; NEUROGENIC STUNNED MYOCARDIUM; NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE; TAKOTSUBO CARDIOMYOPATHY;

AUTONOMIC NEUROPATHY; HEAD INJURY; MUSCULAR DYSTROPHY; NEUROGENIC STUNNED MYOCARDIUM; STROKE; SUBARACHNOID HEMORRHAGE; TAKOTSUBO;

CARDIOVASCULAR DISEASES; HEART; HUMANS; NERVOUS SYSTEM DISEASES; NEURAL PATHWAYS;

EID: 84890874130     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4086-3.00001-1     Document Type: Chapter

References (131)

1. Adams H.P., Alberts M.J., Bhatt D.L., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007, 115:e478-e534.
2. Alboliras E.T., Shub C., Gomez M.R., et al. Spectrum of cardiac involvement in Friedreich's ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 1986, 58:518-524.
3. Allan L.M., Ballard C.G., Allen J., et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 2007, 78:671-677.
4. Alshekhlee A., Hussain Z., Sultan B., et al. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology 2008, 70:1608-1613.
5. Aminoff M.J. Neurology and General Medicine: The Neurological Aspects of Medical Disorders 1995, Churchill Livingstone, New York. 2nd edn.
6. Anan R., Nakagawa M., Miyata M., et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995, 91:955-961.
7. Andreoli A., di Pasquale G., Pinelli G., et al. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke 1987, 18:558-564.
8. Anzola G.P., Frisoni G.B., Morandi E., et al. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006, 37:430-434.
9. Ay H., Koroshetz W.J., Benner T., et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology 2006, 66:1325-1329.
10. Aygun D., Altintop L., Doganay Z., et al. Electrocardiographic changes during migraine attacks. Headache 2003, 43:861-866.
11. Barer D.H., Cruickshank J.M., Ebrahim S.B., et al. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) 1988, 296:737-741.
12. Berenberg R.A., Pellock J.M., DiMauro S., et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome?. Ann Neurol 1977, 1:37-54.
13. Bernstein R., Mayer S.A., Magnano A. Neurogenic stunned myocardium in Guillain-Barre syndrome. Neurology 2000, 54:759-762.
14. Boggs J.G., Painter J.A., DeLorenzo R.J. Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res 1993, 14:87-94.
15. Brockmeier K., Schmitz L., Moers A., et al. X-chromosomal (p21) muscular dystrophy and left ventricular diastolic and systolic function. Pediatr Cardiol 1998, 19:139-144.
16. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy. Part 2. Implementation of multidisciplinary care. Lancet Neurol 2010, 9:177-189.
17. Byer E., Ashman R., Toth L.A. Electrocardiograms with large, upright T waves and long Q-T intervals. Am Heart J 1947, 33:796-806.
18. Carney N.A., Ghajar J. Guidelines for the management of severe traumatic brain injury. Introduction. J Neurotrauma 2007, 24(Suppl 1):S1-S2.
19. Carroll J.D. Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure. Circulation 2008, 117:1358-1360.
20. Chalela J.A., Ezzeddine M.A., Davis L., et al. Myocardial injury in acute stroke: a troponin I study. Neurocrit Care 2004, 1:343-346.
21. Cheung R.T., Hachinski V.C., Cechetto D.F. Cardiovascular response to stress after middle cerebral artery occlusion in rats. Brain Res 1997, 747:181-188.
22. Chiavistelli P., Cei M., Carmignani G., et al. Pseudoischemic electrocardiogram in myasthenia gravis with thymoma: reversibility after thymectomy. Clin Cardiol 2009, 32:E75-E78.
23. Christensen H., Boysen G., Christensen A.F., et al. Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry 2005, 76:269-271.
24. Chung P.W., Won Y.S., Kwon Y.J., et al. Initial troponin level as a predictor of prognosis in patients with intracerebral hemorrhage. J Korean Neurosurg Soc 2009, 45:355-359.
25. Clark D.S., Myerburg R.J., Morales A.R., et al. Heart block in Kearns-Sayre syndrome: electrophysiologic-pathologic correlation. Chest 1975, 68:727-730.
26. Colivicchi F., Bassi A., Santini M., et al. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke 2004, 35:2094-2098.
27. Connuck D.M., Sleeper L.A., Colan S.D., et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008, 155:998-1005.
28. Contant C.F., Valadka A.B., Gopinath S.P., et al. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. J Neurosurg 2001, 95:560-568.
29. Coote J.H. Landmarks in understanding the central nervous control of the cardiovascular system. Exp Physiol 2007, 92:3-18.
30. Courbon F., Brefel-Courbon C., Thalamas C., et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 2003, 18:890-897.
31. Cripe L. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005, 116:1569-1573.
32. Deguchi K., Sasaki I., Tsukaguchi M., et al. Abnormalities of rate-corrected QT intervals in Parkinson's disease - a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002, 199:31-37.
33. Dhamoon M.S., Tai W., Boden-Albala B., et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke 2007, 38:1752-1758.
34. Di Pasquale G., Pinelli G., Andreoli A., et al. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 1987, 59:596-600.
35. Di Pasquale G., Pinelli G., Andreoli A., et al. Torsade de pointes and ventricular flutter-fibrillation following spontaneous cerebral subarachnoid hemorrhage. Int J Cardiol 1988, 18:163-172.
36. Dimant J., Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 1977, 8:448-455.
37. Doshi R., Neil-Dwyer G. Hypothalamic and myocardial lesions after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1977, 40:821-826.
38. Duboc D., Meune C., Lerebours G., et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005, 45:855-857.
39. Durocher A., Servais B., Caridroix M., et al. Autonomic dysfunction in the Guillain-Barre syndrome. Hemodynamic and neurobiochemical studies. Intensive Care Med 1980, 6:3-6.
40. Duru M., Melek I., Seyfeli E., et al. QTc dispersion and P-wave dispersion during migraine attacks. Cephalalgia 2006, 26:672-677.
41. Dziedzic T., Pera J., Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci 2007, 252:53-56.
42. Elahi A., Kelkar P., St Louis E.K. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barre syndrome. Neurocrit Care 2004, 1:465-468.
43. Feldman H.H., Doody R.S., Kivipelto M., et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010, 74:956-964.
44. Finsterer J., Stollberger C. Cardiac involvement in primary myopathies. Cardiology 2000, 94:1-11.
45. Finsterer J., Stollberger C. Atrial fibrillation/flutter in myopathies. Int J Cardiol 2008, 128:304-310.
46. Finsterer J., Stollberger C. Primary myopathies and the heart. Scand Cardiovasc J 2008, 42:9-24.
47. Finsterer J., Bittner R.E., Grimm M. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord 1999, 9:598-600.
48. Flachenecker P., Lem K., Mullges W., et al. Detection of serious bradyarrhythmias in Guillain-Barre syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum. Clin Auton Res 2000, 10:185-191.
49. Forette F., Seux M.L., Staessen J.A., et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002, 162:2046-2052.
50. Furlan J.C., Fehlings M.G. Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurg Focus 2008, 25:E13.
51. Furlund Owe J., Skulstad Davidsen E., Eide G.E., et al. Left ventricular long-axis function in myasthenia gravis. J Neurol 2008, 255:1777-1784.
52. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001, 24:1793-1798.
53. Gibson T.C. The heart in myasthenia gravis. Am Heart J 1975, 90:389-396.
54. Goldstein D.S. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979, 10:253-259.
55. Goldstein D.S., Pechnik S., Holmes C., et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 2003, 42:136-142.
56. Gregoratos G., Cheitlin M.D., Conill A., et al. ACC/AHA Guidelines for Implantation of cardiac pacemakers and antiarrhythmia devices: executive summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998, 97:1325-1335.
57. Groh W.J., Lowe M.R., Zipes D.P. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002, 13:444-448.
58. Guo Z., Viitanen M., Fratiglioni L., et al. Low blood pressure and early death of elderly people with dementia. Lancet 1998, 352:1035-1036.
59. Hall G.C., Brown M.M., Mo J., et al. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563-568.
60. Hays A., Diringer M.N. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006, 66:1330-1334.
61. Hersch C. Electrocardiographic changes in head injuries. Circulation 1961, 23:853-860.
62. Jain R., Deveikis J., Thompson B.G. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol 2004, 25:126-129.
63. Jesurum J.T., Fuller C.J., Kim C.J., et al. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Am J Cardiol 2008, 102:916-920.
64. Jick H., Zornberg G.L., Jick S.S., et al. Statins and the risk of dementia. Lancet 2000, 356:1627-1631.
65. Kawahara E., Ikeda S., Miyahara Y., et al. Role of autonomic nervous dysfunction in electrocardio-graphic abnormalities and cardiac injury in patients with acute subarachnoid hemorrhage. Circ J 2003, 67:753-756.
66. Kothavale A., Banki N.M., Kopelnik A., et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006, 4:199-205.
67. Lee V.H., Oh J.K., Mulvagh S.L., et al. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006, 5:243-249.
68. Lee S.J., Lee K.S., Kim Y.I., et al. Clinical features of patients with a myocardial infarction during acute management of an ischemic stroke. Neurocrit Care 2008, 9:332-337.
69. Lowensohn R.I., Weiss M., Hon E.H. Heart-rate variability in brain-damaged adults. Lancet 1977, 1:626-628.
70. Lyu R.K., Tang L.M., Hsu W.C., et al. A longitudinal cardiovascular autonomic function study in mild Guillain-Barre syndrome. Eur Neurol 2002, 47:79-84.
71. Maramattom B.V., Manno E.M., Fulgham J.R., et al. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc 2006, 81:192-196.
72. Maser R.E., Mitchell B.D., Vinik A.I., et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003, 26:1895-1901.
73. Matsuyama H., Haymaker W. Distribution of lesions in the Landry-Guillain-Barre syndrome, with emphasis on involvement of the sympathetic system. Acta Neuropathol 1967, 8:230-241.
74. Mayer H., Benninger F., Urak L., et al. EKG abnormalities in children and adolescents with symptomatic temporal lobe epilepsy. Neurology 2004, 63:324-328.
75. McEvoy K.M., Windebank A.J., Daube J.R., et al. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989, 321:1567-1571.
76. McGirt M.J., Blessing R., Nimjee S.M., et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004, 54:1369-1373. discussion 1373-1374.
77. Motta J., Guilleminault C., Billingham M., et al. Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies. Am J Med 1979, 67:467-473.
78. Nei M., Ho R.T., Sperling M.R. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia 2000, 41:542-548.
79. Nei M., Ho R.T., Abou-Khalil B.W., et al. EEG and ECG in sudden unexplained death in epilepsy. Epilepsia 2004, 45:338-345.
80. Neil-Dwyer G., Walter P., Cruickshank J.M., et al. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J 1978, 2:990-992.
81. Neil-Dwyer G., Walter P., Cruickshank J.M. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol 1985, 28(Suppl):25-29.
82. Neil-Dwyer G., Cruickshank J., Stratton C. Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhage. Surg Neurol 1986, 25:163-168.
83. O'Suilleabhain P., Low P.A., Lennon V.A. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 1998, 50:88-93.
84. Ogata H., Ishikawa Y., Ishikawa Y., et al. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 2009, 53:72-78.
85. Opherk C., Coromilas J., Hirsch L.J. Heart rate and EKG changes in 102 seizures: analysis of influencing factors. Epilepsy Res 2002, 52:117-127.
86. Oppenheimer S. The anatomy and physiology of cortical mechanisms of cardiac control. Stroke 1993, 24(12 Suppl):I3-I5.
87. Oppenheimer S.M., Gelb A., Girvin J.P., et al. Cardiovascular effects of human insular cortex stimulation. Neurology 1992, 42:1727-1732.
88. Perloff J.K., Roberts W.C., de Leon A.C., et al. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med 1967, 42:179-188.
89. Perloff J.K., Stevenson W.G., Roberts N.K., et al. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 1984, 54:1074-1081.
90. Pfeiffer G., Schiller B., Kruse J., et al. Indicators of dysautonomia in severe Guillain-Barre syndrome. J Neurol 1999, 246:1015-1022.
91. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010, 33:434-441.
92. Pop-Busui R., Evans G.W., Gerstein H.C., et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010, 33:1578-1584.
93. Post M.C., Budts W. The relationship between migraine and right-to-left shunt: fact or fiction?. Chest 2006, 130:896-901.
94. Riera M., Llompart-Pou J.A., Carrillo A., et al. Head injury and inverted takotsubo cardiomyopathy. J Trauma 2010, 68:E13-E15.
95. Rincon F., Dhamoon M., Moon Y., et al. Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke 2008, 39:2425-2431.
96. Riordan W.P., Cotton B.A., Norris P.R., et al. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma 2007, 63:503-510. discussion 510-511.
97. Rokey R., Rolak L.A., Harati Y., et al. Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol 1984, 16:50-53.
98. Royall D.R., Gao J.H., Kellogg D.L. Insular Alzheimer's disease pathology as a cause of "age-related" autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses 2006, 67:747-758.
99. Rugg-Gunn F.J., Simister R.J., Squirrell M., et al. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 2004, 364:2212-2219.
100. Sandhu R., Aronow W.S., Rajdev A., et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 2008, 102:632-634.
101. Sanyal S.K., Johnson W.W. Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: electrocardiographic features and morphologic correlates. Circulation 1982, 66:853-863.
102. Scholte A.J., Schuijf J.D., Delgado V., et al. Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of (123)I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Eur J Nucl Med Mol Imaging 2010, 37:1698-1705.
103. Schwedt T.J. The migraine association with cardiac anomalies, cardiovascular disease, stroke. Neurol Clin 2009, 27:513-523.
104. So E.L. What is known about the mechanisms underlying SUDEP?. Epilepsia 2008, 49(Suppl 9):93-98.
105. Stead L.G., Gilmore R.M., Bellolio M.F., et al. Prolonged QTc as a predictor of mortality in acute ischemic stroke. J Stroke Cerebrovasc Dis 2009, 18:469-474.
106. Sumatriptan Micromedex 2.0 2010, Sumatriptan: DRUGDEX. http://www.micromedex.com.
107. Surges R., Scott C.A., Walker M.C. Enhanced QT shortening and persistent tachycardia after generalized seizures. Neurology 2010, 74:421-426.
108. Suzuki S., Utsugisawa K., Yoshikawa H., et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol 2009, 66:1334-1338.
109. Syverud G. Electrocardiographic changes and intracranial pathology. AANA J 1991, 59:229-232.
110. Talman W.T. Cardiovascular regulation and lesions of the central nervous system. Ann Neurol 1985, 18:1-13.
111. Thijs R.D., Kruit M.C., Avan Buchem M., et al. Syncope in migraine: the population-based CAMERA study. Neurology 2006, 66:1034-1037.
112. Tokgozoglu S.L., Batur M.K., Topuoglu M.A., et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999, 30:1307-1311.
113. Touze E., Varenne O., Chatellier G., et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005, 36:2748-2755.
114. Trujillo-Martin M.M., Serrano-Aguilar P., Monton-Alvarez F., et al. Effectiveness and safety of treatments for degenerative ataxias: a systematic review. Mov Disord 2009, 24:1111-1124.
115. Tuck R.R., McLeod J.G. Autonomic dysfunction in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1981, 44:983-990.
116. Tung P., Kopelnik A., Banki N., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004, 35:548-551.
117. Tzourio C., Anderson C., Chapman N., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003, 163:1069-1075.
118. van Bree M.D., Roos Y.B., van der Bilt I.A., et al. Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage. Neurocrit Care 2010, 12:50-55.
119. van der Bilt I.A., Hasan D., Vandertop W.P., et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009, 72:635-642.
120. Wijdicks E.F., Schievink W.I., Burnett J.C. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg 1997, 87:275-280.
121. Winer J.B., Hughes R.A. Identification of patients at risk of arrhythmia in the Guillain-Barre syndrome. Q J Med 1988, 68:735-739.
122. Wittebole X., Hantson P., Laterre P.F., et al. Electrocardiographic changes after head trauma. J Electrocardiol 2005, 38:77-81.
123. Woods T.D., Harmann L., Purath T., et al. Small- and moderate-size right-to-left shunts identified by saline contrast echocardiography are normal and unrelated to migraine headache. Chest 2010, 138:264-269.
124. Yilmaz A., Gdynia H.J., Baccouche H., et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008, 10:50.
125. Yokota R., Shirotani M., Kouchi I., et al. Subclinical Becker's muscular dystrophy presenting with severe heart failure. Intern Med 2004, 43:204-208.
126. Yoshii F., Kozuma R., Haida M., et al. Giant negative T waves in Guillain-Barre syndrome. Acta Neurol Scand 2000, 101:212-215.
127. Yoshimura S., Toyoda K., Ohara T., et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 2008, 64:547-554.
128. Young L.H., Wackers F.J., Chyun D.A., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009, 301:1547-1555.
129. Zanettini R., Antonini A., Gatto G., et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007, 356:39-46.
130. Zijlmans M., Flanagan D., Gotman J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 2002, 43:847-854.
131. Zulli R., Nicosia F., Borroni B., et al. QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. J Am Geriatr Soc 2005, 53:2135-2139.